AIM-quoted Eden Research, which focuses on sustainable bio-control solutions for the global crop protection, animal health and consumer products industries, has announced an exclusive commercialisation, supply and distribution agreement with Corteva Agriscience for Eden’s first broadacre seed treatment product.
Corteva, formed through the 2019 merger of Dow Agrosciences, DuPont Crop Protection and DuPont Pioneer, is a global supplier of seeds for a wide range of crops.
The agreement follows Corteva’s successful evaluations of Eden’s products and technology for select seed treatment applications since late 2019. It grants exclusive rights to Corteva for the development, commercialisation and distribution of Eden’s first seed treatment product for use in the European Union, UK and Serbia.
The seed treatment is based on Eden’s registered active ingredients that are delivered using its novel, patented Sustaine encapsulation technology, based on natural, plastic-free, biodegradable micro-spheres. The companies intend to collaborate on the evaluation of additional uses of Eden’s products and technology in the world seed treatment market.
Sean Smith, chief executive of Eden Research, comments: “The agreement with Corteva is a defining moment for Eden and clearly demonstrates the next major step in the development of a new product in the significant seed treatment market, whilst also expanding our product coverage to broadacre crops.
“Corteva is one of the largest agriculture input companies in the world and has extensive expertise in the seed treatments field. We are delighted to be working with Corteva to help meet the needs of farmers who are increasingly aware of the need to source sustainable farming inputs to ensure a greener future.